- Clinical Trials
- April 2024
- 85 Pages
Global
From €1942EUR$2,000USD£1,660GBP
- Clinical Trials
- April 2024
- 250 Pages
Global
From €2914EUR$3,000USD£2,489GBP
- Drug Pipelines
- April 2024
- 100 Pages
Global
From €2914EUR$3,000USD£2,489GBP
- Clinical Trials
- April 2024
- 240 Pages
Global
From €2914EUR$3,000USD£2,489GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1457EUR$1,500USD£1,245GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1457EUR$1,500USD£1,245GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1942EUR$2,000USD£1,660GBP
- Report
- March 2024
- 134 Pages
Global
From €7721EUR$7,950USD£6,597GBP
- Report
- February 2024
- 450 Pages
Global
From €4856EUR$5,000USD£4,149GBP
- Report
- January 2024
- 175 Pages
Global
From €9227EUR$9,500USD£7,883GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1457EUR$1,500USD£1,245GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1457EUR$1,500USD£1,245GBP
- Report
- February 2024
- 172 Pages
Global
From €4759EUR$4,900USD£4,066GBP
- Report
- December 2023
- 163 Pages
Global
From €2428EUR$2,500USD£2,074GBP
- Report
- November 2023
- 150 Pages
Global
From €3093EUR$3,185USD£2,643GBP
€4419EUR$4,550USD£3,775GBP
- Report
- March 2024
- 200 Pages
Global
From €4031EUR$4,150USD£3,443GBP
- Report
- July 2023
- 85 Pages
Global
From €3394EUR$3,495USD£2,900GBP
- Report
- December 2023
- 297 Pages
Global
€4851EUR$4,995USD£4,145GBP
- Report
- July 2023
- 179 Pages
Global
From €4371EUR$4,500USD£3,734GBP
- Report
- May 2023
- 85 Pages
United States
From €5779EUR$5,950USD£4,937GBP
The Immunoglobulin market is a segment of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Immunoglobulin (Ig) is a type of protein found in the blood that helps fight infection and disease. It is used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and infections. Immunoglobulin therapies are typically administered intravenously or subcutaneously, and can be used to replace or supplement the body's natural Ig production.
The Immunoglobulin market is highly competitive, with a number of companies offering a range of products. These products vary in terms of dosage, delivery method, and cost. Companies in the market are focused on developing new therapies and improving existing ones, as well as expanding their product portfolios.
Some of the major companies in the Immunoglobulin market include CSL Behring, Grifols, Kedrion, Octapharma, and Shire. Show Less Read more